From Name:
From Email:
To Name:
To Email:

Optional Message:


Topas COC helps mold next-gen wearable insulin delivery devices

from Plastics Today

More than 30 million people in the United States are diagnosed with diabetes, and it is the most costly chronic disease in the country, according to the American Diabetes Association. Fortunately, medtech companies continue to harness technology to develop more-effective, patient-friendly devices to manage diabetes. Cyclic olefin co-polymers (COCs) from Polyplastics Co., Ltd. (Florence, KY) are playing a significant role in the development of these next-generation devices. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063